Literature DB >> 17443643

Modeling the proteome of a Marek's disease transformed cell line: a natural animal model for CD30 overexpressing lymphomas.

Joram J Buza1, Shane C Burgess.   

Abstract

Marek's disease (MD) in the chicken, caused by the highly infectious MD alpha-herpesvirus (MDV), is both commercially important and a unique, naturally occurring model for human T-cell lymphomas overexpressing the Hodgkin's disease antigen, CD30. Here, we used proteomics as a basis for modeling the molecular functions and biological processes involved in MDV-induced lymphomagenesis. Proteins were extracted from an MDV-transformed cell line and were then identified using 2-D LC-ESI-MS/MS. From the resulting 3870 cellular and 21 MDV proteins we confirm the existence of 3150 "predicted" and 12 "hypothetical" chicken proteins. The UA-01 proteome is proliferative, differentiated, angiogenic, pro-metastatic and pro-immune-escape but anti-programmed cell death, -anergy, -quiescence and -senescence and is consistent with a cancer phenotype. In particular, the pro-metastatic integrin signaling pathway and the ERK/MAPK signaling pathways were the two predominant signaling pathways represented. The cytokines, cytokine receptors, and their related proteins suggest that UA-01 has a regulatory T-cell phenotype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17443643     DOI: 10.1002/pmic.200600946

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  12 in total

1.  Integrated analyses of genome-wide DNA occupancy and expression profiling identify key genes and pathways involved in cellular transformation by a Marek's disease virus oncoprotein, Meq.

Authors:  Sugalesini Subramaniam; John Johnston; Likit Preeyanon; C Titus Brown; Hsing-Jien Kung; Hans H Cheng
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

2.  Identification of an intercistronic internal ribosome entry site in a Marek's disease virus immediate-early gene.

Authors:  Abdessamad Tahiri-Alaoui; Lorraine P Smith; Suzan Baigent; Lydia Kgosana; Lawrence J Petherbridge; Luke S Lambeth; William James; Venugopal Nair
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

3.  Global liver proteomics of rats exposed for 5 days to phenobarbital identifies changes associated with cancer and with CYP metabolism.

Authors:  Mary B Dail; L Allen Shack; Janice E Chambers; Shane C Burgess
Journal:  Toxicol Sci       Date:  2008-09-16       Impact factor: 4.849

4.  The 5' leader of the mRNA encoding the marek's disease virus serotype 1 pp14 protein contains an intronic internal ribosome entry site with allosteric properties.

Authors:  Abdessamad Tahiri-Alaoui; Daiki Matsuda; Hongtao Xu; Panopoulos Panagiotis; Luke Burman; Luke S Lambeth; Lawrence Petherbridge; William James; Vincent Mauro; Venugopal Nair
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

5.  MicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs.

Authors:  Yongxiu Yao; Yuguang Zhao; Hongtao Xu; Lorraine P Smith; Charles H Lawrie; Michael Watson; Venugopal Nair
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

6.  Systems analysis of immune responses in Marek's disease virus-infected chickens identifies a gene involved in susceptibility and highlights a possible novel pathogenicity mechanism.

Authors:  Jacqueline Smith; Jean-Remy Sadeyen; Ian R Paton; Paul M Hocking; Nigel Salmon; Mark Fife; Venugopal Nair; David W Burt; Pete Kaiser
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

7.  Nuclear Factor kappa B is central to Marek's disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo.

Authors:  Shyamesh Kumar; Dusan Kunec; Joram J Buza; Hsin-I Chiang; Huaijun Zhou; Sugalesini Subramaniam; Ken Pendarvis; Hans H Cheng; Shane C Burgess
Journal:  BMC Syst Biol       Date:  2012-09-14

8.  GOModeler--a tool for hypothesis-testing of functional genomics datasets.

Authors:  Prashanti Manda; McKinley G Freeman; Susan M Bridges; T J Jankun-Kelly; Bindu Nanduri; Fiona M McCarthy; Shane C Burgess
Journal:  BMC Bioinformatics       Date:  2010-10-07       Impact factor: 3.169

9.  Genotype-dependent tumor regression in Marek's disease mediated at the level of tumor immunity.

Authors:  Shyamesh Kumar; Joram J Buza; Shane C Burgess
Journal:  Cancer Microenviron       Date:  2009-03-18

10.  Prediction of peptides observable by mass spectrometry applied at the experimental set level.

Authors:  William S Sanders; Susan M Bridges; Fiona M McCarthy; Bindu Nanduri; Shane C Burgess
Journal:  BMC Bioinformatics       Date:  2007-11-01       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.